CJC-1295 With DAC : A Powerful Growth Hormone Pumping Agent
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide designed to stimulate natural growth hormone (GH) production. It is a modified version of growth hormone–releasing hormone (GHRH) that increases circulating GH and insulin-like growth factor-1 (IGF-1) levels over an extended period. Because of its prolonged half-life, CJC-1295 with DAC is often discussed in hormone optimization, muscle growth, anti-aging, fat metabolism, recovery and performance research settings.
Learn more about this peptide’s fat loss potential by reading our blog post here.
What Does “With DAC” Mean?
The Drug Affinity Complex (DAC) allows CJC-1295 to bind to albumin in the bloodstream. This binding significantly extends its half-life compared to short-acting GHRH analogs.
Half-life: Approximately 6–8 days
Dosing frequency: Often once or twice weekly (in research contexts)
Effect: Sustained elevation of GH and IGF-1
This differs from CJC-1295 without DAC (Mod GRF 1-29), which produces shorter, more pulsatile GH release.
How CJC-1295 With DAC Works
CJC-1295 With DAC acts on the anterior pituitary gland to stimulate endogenous growth hormone secretion. By increasing GH levels, it may:
Elevate IGF-1 production
Support muscle protein synthesis
Enhance fat metabolism
Improve tissue repair
Unlike direct HGH injections, it stimulates the body’s own hormone production rather than replacing it.
Potential Benefits of CJC-1295 With DAC
Research and clinical interest suggest the following potential effects and support:
1. Lean Muscle Growth
Higher GH and IGF-1 levels can promote muscle hypertrophy and recovery.
2. Fat Loss and Improved Body Composition
GH plays a role in lipolysis (fat breakdown), particularly in stubborn body fat areas.
3. Recovery and Repair
May support connective tissue repair, joint health, and post-exercise recovery.
4. Anti-Aging and Wellness
GH is associated with skin elasticity, sleep quality, and overall vitality.
CJC-1295 With DAC vs. Without DAC
| Feature | CJC-1295 With DAC | CJC-1295 (No DAC / Mod GRF 1-29) |
|---|---|---|
| Half-Life | 6–8 days | 30–60 minutes |
| GH Release | Sustained elevation | Pulsatile, short bursts |
| Dosing | Weekly | Daily or multiple daily |
| IGF-1 Impact | Higher sustained levels | More physiological pattern |
The “with DAC” version provides longer-lasting effects but less natural pulsatility compared to the short-acting form.
Side Effects and Safety Considerations
As with any growth hormone stimulating compound, potential side effects may include:
Injection site reactions (redness, minor swelling)
Water retention
Joint stiffness
Numbness or tingling
Headache
- Flushing
Because it elevates growth hormone levels, it may also impact insulin sensitivity in some individuals.
Regulatory Status
CJC-1295 With DAC is not yet FDA-approved for general therapeutic use.
It is primarily available as a research peptide.
Long-term human safety data is limited.
Anyone considering growth hormone–modulating therapies should always consult a licensed healthcare provider. Individual responses may vary. This information is for educational purposes only and should not be considered medical advice.
Is CJC-1295 With DAC Right for You?
CJC-1295 With DAC is typically discussed in the context of:
Hormone optimization research
Body composition enhancement
Recovery and regenerative protocols
Because of its long half-life and sustained GH elevation, it is generally chosen by individuals seeking less frequent dosing compared to short-acting alternatives.
Where Can I Learn More?
1. Human clinical trial (gold standard study)
- Prolonged Stimulation of Growth Hormone and IGF-1 by CJC-1295
- Randomized, placebo-controlled trial showing significant increases in GH and IGF-1 levels in healthy adults after administration.
2. Growth hormone secretion & pulsatility study
- Pulsatile Secretion of Growth Hormone Persists with CJC-1295
- Demonstrated increased GH and IGF-1 levels while preserving natural pulsatile secretion patterns.
3. Mechanism & biomarker research (human study)
- Activation of the GH/IGF-1 Axis by CJC-1295
- Showed elevated GH/IGF-1 and associated protein changes, helping identify biomarkers of activity.
4. Preclinical growth & body composition study
- Once-Daily Administration of CJC-1295 in GHRHKO Mice
- Found improved growth, body composition, and increased GH expression in treated animals.
Common Stacks & Related Peptides
CJC-1295 With DAC combined with Ipamorelin is one of the most popular peptide stacks on the market as the two provide a powerful synergy to maximize growth hormone levels. CJC-1295 has also been paired with other growth hormone analogs like Tesamorelin to maximize fat loss, especially belly visceral fat, while promoting lean muscle growth and improving body composition. CJC-1295 has also been combined with BPC-157 to enhance healing and tissue repair. CJC-1295 is widely used in the growth hormone category amongst adult researchers.
